Skip to main content
OpenTrials
Completed

NCT Number: NCT00212654

Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in postoperative supraventricular tachyarrhythmias.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Supraventricular Tachyarrythmia

Age range

21 year–84 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 20 years or older
  • Postoperative supraventricular tachyarrhythmias
  • Within 7 days postoperatively
  • Other inclusion criteria as specified in the protocol

Exclusion criteria

  • Acute myocardial infarction (within 1 month after onset)
  • Severe heart failure [New York Heart Association (NYHA) functional class III or higher]
  • Atrioventricular block (grade II or higher), or sick sinus syndrome
  • Other exclusion criteria as specified in the protocol

Treatment and study plan

ONO-1101

Drug

Primary outcomes

  1. Percentage of patients who met the heart rate reduction criteria (20% reduction from the baseline heart rate and a heart rate of <100 beats/min)

Secondary outcomes

  1. Heart rate, blood pressure, rate-pressure-product and ECG

Sponsors and collaborators

Lead sponsor

Ono Pharmaceutical Co., Ltd.

Industry

Registry information

Important dates

Study start
2001
Primary completion
2006
First posted
Sep 21, 2005
Registry last updated
Oct 11, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.